Mytogen, Inc. Report issue

For profit Phase 2
Founded: Alexandria VA United States (1990)
Status: Acquired by Ocata Therapeutics (2007) → now Leo Pharma (2015)

Organization Overview

First Clinical Trial
2008
NCT00626314
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

autologous skeletal myoblast (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiomyopathies (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1